Business Description
PURE Bioscience Inc
NAICS : 325620
SIC : 2843
ISIN : US74621T2096
Description
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | -1.22 | |||||
| Debt-to-Equity | -1.41 | |||||
| Debt-to-EBITDA | -0.54 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -180.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -40.8 | |||||
| 3-Year Book Growth Rate | -66.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.28 | |||||
| 9-Day RSI | 43.26 | |||||
| 14-Day RSI | 43.37 | |||||
| 6-1 Month Momentum % | -12.87 | |||||
| 12-1 Month Momentum % | 3.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.72 | |||||
| Quick Ratio | 1.59 | |||||
| Cash Ratio | 1.02 | |||||
| Days Inventory | 48.75 | |||||
| Days Sales Outstanding | 40.71 | |||||
| Days Payable | 179.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.23 | |||||
| Operating Margin % | -158.44 | |||||
| Net Margin % | -177.2 | |||||
| FCF Margin % | -132.62 | |||||
| ROE % | -964.29 | |||||
| ROA % | -191.54 | |||||
| ROIC % | -938.65 | |||||
| ROC (Joel Greenblatt) % | -1029.09 | |||||
| ROCE % | -270.68 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.96 | |||||
| EV-to-EBIT | -2.56 | |||||
| EV-to-EBITDA | -2.65 | |||||
| EV-to-Revenue | 4.44 | |||||
| EV-to-FCF | -3.23 | |||||
| Price-to-Median-PS-Value | 0.18 | |||||
| Earnings Yield (Greenblatt) % | -39.06 | |||||
| FCF Yield % | -34.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PURE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PURE Bioscience Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.057 | ||
| EPS (TTM) ($) | -0.04 | ||
| Beta | 0.46 | ||
| Volatility % | 86.56 | ||
| 14-Day RSI | 43.37 | ||
| 14-Day ATR ($) | 0.008106 | ||
| 20-Day SMA ($) | 0.076325 | ||
| 12-1 Month Momentum % | 3.53 | ||
| 52-Week Range ($) | 0.063 - 0.167 | ||
| Shares Outstanding (Mil) | 111.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PURE Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PURE Bioscience Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
PURE Bioscience Inc Frequently Asked Questions
What is PURE Bioscience Inc(PURE)'s stock price today?
The current price of PURE is $0.07. The 52 week high of PURE is $0.17 and 52 week low is $0.06.
When is next earnings date of PURE Bioscience Inc(PURE)?
The next earnings date of PURE Bioscience Inc(PURE) is 2024-06-14 Est..
Does PURE Bioscience Inc(PURE) pay dividends? If so, how much?
PURE Bioscience Inc(PURE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers